These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12113035)

  • 1. Pharmacogenetics of cytotoxic drugs.
    Daly AK; Hall AG
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):301-8. PubMed ID: 12113035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics in cancer etiology and chemotherapy.
    Boddy AV; Ratain MJ
    Clin Cancer Res; 1997 Jul; 3(7):1025-30. PubMed ID: 9815780
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction.
    ;
    Invest New Drugs; 2005 Dec; 23(6):511. PubMed ID: 16391895
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of studies of selected metabolic polymorphisms and cancer.
    d'Errico A; Malats N; Vineis P; Boffetta P
    IARC Sci Publ; 1999; (148):323-93. PubMed ID: 10493265
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic testing for pharmacogenetics and its clinical application in drug therapy.
    Hiratsuka M; Sasaki T; Mizugaki M
    Clin Chim Acta; 2006 Jan; 363(1-2):177-86. PubMed ID: 16126184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug methylation in cancer therapy: lessons from the TPMT polymorphism.
    Krynetski E; Evans WE
    Oncogene; 2003 Oct; 22(47):7403-13. PubMed ID: 14576848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 pharmacogenetics and cancer.
    Rodriguez-Antona C; Ingelman-Sundberg M
    Oncogene; 2006 Mar; 25(11):1679-91. PubMed ID: 16550168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer pharmacogenomics: international trends.
    Yamayoshi Y; Iida E; Tanigawara Y
    Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.
    Candelaria M; Taja-Chayeb L; Arce-Salinas C; Vidal-Millan S; Serrano-Olvera A; Dueñas-Gonzalez A
    Anticancer Drugs; 2005 Oct; 16(9):923-33. PubMed ID: 16162969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacogenetics and pharmacogenomics. Searching for individual antihypertensive therapy concepts].
    Brand E
    MMW Fortschr Med; 2003 May; 145(19):43-4. PubMed ID: 12813978
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenetics of drug metabolizing enzymes in the United Kingdom population: review of current knowledge and comparison with selected European populations.
    Daly AK
    Drug Metab Pers Ther; 2015 Sep; 30(3):165-74. PubMed ID: 25803091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of cancer chemotherapy-induced toxicity.
    Miller CR; McLeod HL
    J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer pharmacogenomics: achievements in basic research.
    Nakajima M; Yokoi T
    Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
    Hasegawa Y
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
    Wang L; Weinshilboum R
    Oncogene; 2006 Mar; 25(11):1629-38. PubMed ID: 16550163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
    Hiratsuka M; Mizugaki M
    Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
    [No Abstract]   [Full Text] [Related]  

  • 18. [Polymorphism of enzymes involved in drug metabolism: gene structure and enzymatic activity].
    Krynetskiĭ EI
    Mol Biol (Mosk); 1996; 30(1):33-42. PubMed ID: 8714120
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
    Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
    Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM; Meijerman I; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.